ABS-201: Shot that targets Prolactin hormone to prevent hair loss
Scientists have successfully completed early testing for ABS-201, an AI-designed antibody that stops the hormone prolactin from “shutting down” hair growth. Trial data released on May 7, 2026, confirmed the treatment is safe and highly effective at maintaining a constant growth signal in the scalp. Because the medication is “long-acting,” patients only need two or three injections over a six-month period to achieve results that previously required taking a pill or applying foam every single day.
